( 06185.hk) | -62.69 | 1.64 | 0% | 上市时间2019-03-28股价35.72港币涨跌幅-2.78%成交金额5,508.82万港币换手率0.62%市值88.24亿港币H股市值47.39亿港币总股本2.47亿H股本1.33亿每手股数200上市至今年化投资收益率0.11%港股通持仓占H股比例35.59% (18.83亿港币2026-01-26) 累计做空占H股比例1.07% (5,314.25万港币2026-01-16) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 67.63 | 市净率 | 5.13 | 股息率 | 0.30% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (3): | 双击编辑备注 |
康希诺生物(06185) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 王靖 | Executive Director | 2021-10-11 | -- | |
| 2 | 桂水發 | Independent Non Executive Director | 2019-11-29 | -- | |
| 3 | 劉建忠 | Independent Non Executive Director | 2019-11-29 | -- | |
| 4 | 肖治 | Non Executive Director | 2019-06-28 | -- | |
| 5 | 韋少琨 | Independent Non Executive Director | 2018-06-22 | -- | |
| 6 | 辛珠 | Independent Non Executive Director - A/F | 2018-06-22 | -- | |
| 7 | BARRETO Luis | Independent Non Executive Director | 2018-06-22 | 2019-11-29 | |
| 8 | MORGON Pierre Armand | Independent Non Executive Director | 2018-06-22 | 2019-11-29 | |
| 9 | CHAO Shou Bai | Executive Director | 2018-05-01 | -- | |
| 10 | 尹正 | Non Executive Director | 2017-04-12 | 2019-06-28 | |
| 11 | 梁頴宇 | Non Executive Director | 2015-09-16 | -- | |
| 12 | 林亮 | Non Executive Director | 2013-08-06 | -- | |
| 13 | 許強 | Non Executive Director | 2011-12-31 | 2021-09-10 | |
| 14 | QIU Dong Xu | Executive Director | 2009-01-13 | -- | |
| 15 | YU Xue Feng | Executive Director | Chairman, CEO, Managing Director | 2009-01-13 | -- |
| 16 | 朱濤 | Executive Director | 2009-01-13 | -- |